ExPASy logo ExPASy Home page Site Map Search ExPASy Contact us Swiss-Prot
Notice: This page will be replaced with www.uniprot.org. Please send us your feedback!
Search for

UniProtKB/Swiss-Prot entry P07320


[Entry info] [Name and origin] [References] [Comments] [Cross-references] [Keywords] [Features] [Sequence] [Tools]

Note: most headings are clickable, even if they don't appear as links. They link to the user manual or other documents.
Entry information
Entry name CRGD_HUMAN
Primary accession number P07320
Secondary accession numbers Q17RF7 Q53R51 Q99681
Integrated into Swiss-Prot on April 1, 1988
Sequence was last modified on January 23, 2007 (Sequence version 3)
Annotations were last modified on    November 25, 2008 (Entry version 100)
Name and origin of the protein
Protein name Gamma-crystallin D
Synonyms Gamma-D-crystallin
Gamma-crystallin 4
Gene name
Name: CRYGD
Synonyms: CRYG4
From
Homo sapiens (Human) [TaxID: 9606] 
Taxonomy Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; Homo.
Protein existence 1: Evidence at protein level;
References
[1]
NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT VAL-102.
PubMed=4033658 [NCBI, ExPASy, EBI, Israel, Japan]
Meakin S.O., Breitman M.L., Tsui L.-C.;
"Structural and evolutionary relationships among five members of the human gamma-crystallin gene family.";
Mol. Cell. Biol. 5:1408-1414(1985).
[2]
NUCLEOTIDE SEQUENCE [MRNA].
TISSUE=Lens;
Petrash J.M., Mathur S., Manoharan M., Andley U.P.;
"Cloning and expression of human lens crystallins.";
Invest. Ophthalmol. Vis. Sci. 36:S882-S882(1995).
[3]
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
DOI=10.1038/nature03466; PubMed=15815621 [NCBI, ExPASy, EBI, Israel, Japan]
Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K., McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C., Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C., Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S., Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H., Wilson R.K.;
"Generation and annotation of the DNA sequences of human chromosomes 2 and 4.";
Nature 434:724-731(2005).
[4]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
TISSUE=Testis;
DOI=10.1101/gr.2596504; PubMed=15489334 [NCBI, ExPASy, EBI, Israel, Japan]
The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
[5]
PROTEIN SEQUENCE OF 2-11.
DOI=10.1074/jbc.272.4.2268; PubMed=8999933 [NCBI, ExPASy, EBI, Israel, Japan]
Lampi K.J., Ma Z., Shih M., Shearer T.R., Smith J.B., Smith D.L., David L.L.;
"Sequence analysis of betaA3, betaB3, and betaA4 crystallins completes the identification of the major proteins in young human lens.";
J. Biol. Chem. 272:2268-2275(1997).
[6]
SUSCEPTIBILITY TO OXIDATION, AND MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
DOI=10.1073/pnas.122231399; PubMed=12060738 [NCBI, ExPASy, EBI, Israel, Japan]
MacCoss M.J., McDonald W.H., Saraf A., Sadygov R., Clark J.M., Tasto J.J., Gould K.L., Wolters D., Washburn M., Weiss A., Clark J.I., Yates J.R. III;
"Shotgun identification of protein modifications from protein complexes and lens tissue.";
Proc. Natl. Acad. Sci. U.S.A. 99:7900-7905(2002).
[7]
MUTAGENESIS OF PRO-24.
DOI=10.1021/bi0479611; PubMed=15709761 [NCBI, ExPASy, EBI, Israel, Japan]
Pande A., Annunziata O., Asherie N., Ogun O., Benedek G.B., Pande J.;
"Decrease in protein solubility and cataract formation caused by the Pro23 to Thr mutation in human gamma D-crystallin.";
Biochemistry 44:2491-2500(2005).
[8]
X-RAY CRYSTALLOGRAPHY (1.25 ANGSTROMS), AND X-RAY CRYSTALLOGRAPHY (1.15 ANGSTROMS) OF VARIANT HIS-59.
DOI=10.1016/S0022-2836(03)00375-9; PubMed=12729747 [NCBI, ExPASy, EBI, Israel, Japan]
Basak A., Bateman O., Slingsby C., Pande A., Asherie N., Ogun O., Benedek G.B., Pande J.;
"High-resolution X-ray crystal structures of human gammaD crystallin (1.25 A) and the R58H mutant (1.15 A) associated with aculeiform cataract.";
J. Mol. Biol. 328:1137-1147(2003).
[9]
3D-STRUCTURE MODELING.
DOI=10.1016/S0006-291X(02)02895-4; PubMed=12507494 [NCBI, ExPASy, EBI, Israel, Japan]
Salim A., Zaidi Z.H.;
"Homology models of human gamma-crystallins: structural study of the extensive charge network in gamma-crystallins.";
Biochem. Biophys. Res. Commun. 300:624-630(2003).
[10]
VARIANT CACA HIS-59.
DOI=10.1086/302619; PubMed=10521291 [NCBI, ExPASy, EBI, Israel, Japan]
Heon E., Priston M., Schorderet D.F., Billingsley G.D., Girard P.O., Lubsen N., Munier F.L.;
"The gamma-crystallins and human cataracts: a puzzle made clearer.";
Am. J. Hum. Genet. 65:1261-1267(1999).
[11]
VARIANT PROGRESSIVE PUNCTATE CATARACT CYS-15.
DOI=10.1073/pnas.96.3.1008; PubMed=9927684 [NCBI, ExPASy, EBI, Israel, Japan]
Stephan D.A., Gillanders E., Vanderveen D., Freas-Lutz D., Wistow G., Baxevanis A.D., Robbins C.M., VanAuken A., Quesenberry M.I., Bailey-Wilson J., Juo S.-H.H., Trent J.M., Smith L., Brownstein M.J.;
"Progressive juvenile-onset punctate cataracts caused by mutation of the gamma-D-crystallin gene.";
Proc. Natl. Acad. Sci. U.S.A. 96:1008-1012(1999).
[12]
VARIANT CATARACT SER-37.
DOI=10.1093/hmg/9.12.1779; PubMed=10915766 [NCBI, ExPASy, EBI, Israel, Japan]
Kmoch S., Brynda J., Asfaw B., Bezouska K., Novak P., Rezacova P., Ondrova L., Filipec M., Sedlacek J., Elleder M.;
"Link between a novel human gamma-D-crystallin allele and a unique cataract phenotype explained by protein crystallography.";
Hum. Mol. Genet. 9:1779-1786(2000).
[13]
CHARACTERIZATION OF VARIANT PROGRESSIVE PUNCTATE CATARACT CYS-15.
DOI=10.1073/pnas.040554397; PubMed=10688888 [NCBI, ExPASy, EBI, Israel, Japan]
Pande A., Pande J., Asherie N., Lomakin A., Ogun O., King J.A., Lubsen N.H., Walton D., Benedek G.B.;
"Molecular basis of a progressive juvenile-onset hereditary cataract.";
Proc. Natl. Acad. Sci. U.S.A. 97:1993-1998(2000).
[14]
CHARACTERIZATION OF VARIANTS CATARACT SER-37 AND HIS-59.
DOI=10.1073/pnas.101124798; PubMed=11371638 [NCBI, ExPASy, EBI, Israel, Japan]
Pande A., Pande J., Asherie N., Lomakin A., Ogun O., King J., Benedek G.B.;
"Crystal cataracts: human genetic cataract caused by protein crystallization.";
Proc. Natl. Acad. Sci. U.S.A. 98:6116-6120(2001).
[15]
VARIANT LAMELLAR CATARACT THR-24, AND VARIANT VAL-102.
DOI=10.1136/jmg.39.5.352; PubMed=12011157 [NCBI, ExPASy, EBI, Israel, Japan]
Santhiya S.T., Shyam Manohar M., Rawlley D., Vijayalakshmi P., Namperumalsamy P., Gopinath P.M., Loester J., Graw J.;
"Novel mutations in the gamma-crystallin genes cause autosomal dominant congenital cataracts.";
J. Med. Genet. 39:352-358(2002).
[16]
VARIANT CCA3 THR-24.
DOI=10.1136/jmg.40.4.262; PubMed=12676897 [NCBI, ExPASy, EBI, Israel, Japan]
Nandrot E., Slingsby C., Basak A., Cherif-Chefchaouni M., Benazzouz B., Hajaji Y., Boutayeb S., Gribouval O., Arbogast L., Berraho A., Abitbol M., Hilal L.;
"Gamma-D crystallin gene (CRYGD) mutation causes autosomal dominant congenital cerulean cataracts.";
J. Med. Genet. 40:262-267(2003).
[17]
VARIANT PCC ALA-107.
PubMed=16943771 [NCBI, ExPASy, EBI, Israel, Japan]
Messina-Baas O.M., Gonzalez-Huerta L.M., Cuevas-Covarrubias S.A.;
"Two affected siblings with nuclear cataract associated with a novel missense mutation in the CRYGD gene.";
Mol. Vis. 12:995-1000(2006).
[18]
VARIANT PCC SER-24.
DOI=10.1086/518616; PubMed=17564961 [NCBI, ExPASy, EBI, Israel, Japan]
Plotnikova O.V., Kondrashov F.A., Vlasov P.K., Grigorenko A.P., Ginter E.K., Rogaev E.I.;
"Conversion and compensatory evolution of the gamma-crystallin genes and identification of a cataractogenic mutation that reverses the sequence of the human CRYGD gene to an ancestral state.";
Am. J. Hum. Genet. 81:32-43(2007).
Comments
  • FUNCTION: Crystallins are the dominant structural components of the vertebrate eye lens.
  • SUBUNIT: Monomer (By similarity).
  • DOMAIN: Has a two-domain beta-structure, folded into four very similar Greek key motifs.
  • DISEASE: Defects in CRYGD are a cause of various types of autosomal dominant cataract [MIM:604219]. Cataracts are common major abnormalities of the eye that frequently cause blindness in infants.
  • DISEASE: Defects in CRYGD are the cause of autosomal dominant non-nuclear polymorphic congenital cataract (PCC) [MIM:601286]; also known as polymorphic congenital cataract. PCC is characterized by a nonprogressive phenotype and partial opacity that has a variable location on the periphery between the fetal nucleus of the lens and the equator. The opacities are irregular and look similar to a bunch of grapes and may be present simultaneously in different lens layers.
  • DISEASE: Defects in CRYGD are the cause of congenital cerulean cataract 3 (CCA3) [MIM:608983]; also known as congenital cataract blue dot type 3. CCA3 is a form of autosomal dominant congenital cataract (ADCC). Cerulean cataracts have peripheral bluish and white opacifications in concentric layers with occasional central lesions arranged radially. Although the opacities may be observed during fetal development and childhood, usually visual acuity is only mildly reduced until adulthood, when lens extraction is generally necessary.
  • DISEASE: Defects in CRYGD are the cause of progressive punctate cataract [MIM:123690]. It is an autosomal dominant trait characterized by early postnatal onset.
  • DISEASE: Defects in CRYGD are the cause of crystalline aculeiform cataract (CACA) [MIM:115700]. CACA is a congenital crystalline cataract characterized by fiberglass-like or needle-like crystals through or close to the axial regions of the lens.
  • SIMILARITY: Belongs to the beta/gamma-crystallin family.
  • SIMILARITY: Contains 4 beta/gamma crystallin 'Greek key' domains.
  • WEB RESOURCE: Name=GeneReviews; URL="http://www.genetests.org/query?gene=CRYGD";.
Copyright
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms. Distributed under the Creative Commons Attribution-NoDerivs License.
Cross-references
Sequence databases
EMBL
K03006; AAA52112.1; -; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
K03005; AAA52112.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
U66583; AAB38686.1; -; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
AC093698; AAY24041.1; -; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
BC117338; AAI17339.1; -; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
BC117340; AAI17341.1; -; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
PIR I77413; I77413.
RefSeq NP_008822.2; -.
UniGene Hs.546247
3D structure databases
PDB
1H4A; X-ray; 1.15 A; X=1-174.[ExPASy / RCSB / EBI]
1HK0; X-ray; 1.25 A; X=1-174.[ExPASy / RCSB / EBI]
1LD0; Model; -; A=1-174.[ExPASy / RCSB / EBI]
2G98; X-ray; 2.20 A; A/B=1-174.[ExPASy / RCSB / EBI]
Detailed list of linked structures.
PDBsum 1H4A; -.
1HK0; -.
1LD0; -.
2G98; -.
ModBase P07320.
PTM databases
PhosphoSite P07320; -.
Organism-specific databases
H-InvDB HIX0030025; -.
HGNC HGNC:2411; CRYGD.
GenAtlas CRYGD.
MIM 115700; phenotype. [NCBI / EBI]
123690; gene+phenotype. [NCBI / EBI]
601286; phenotype. [NCBI / EBI]
604219; phenotype. [NCBI / EBI]
608983; phenotype. [NCBI / EBI]
Orphanet 98989; Cataract, cerulean.
91492; Cataract, congenital, non-syndromic.
PharmGKB PA26918; -.
GeneCards P07320.
Gene expression databases
ArrayExpress P07320; -.
CleanEx HS_CRYGD; -.
GermOnline ENSG00000118231; Homo sapiens.
Ontologies
GO
GO:0005212; Molecular function: structural constituent of eye lens (inferred from electronic annotation from UniProtKB-KW).
GO:0050896; Biological process: response to stimulus (inferred from electronic annotation from UniProtKB-KW).
GO:0007601; Biological process: visual perception (traceable author statement from ProtInc).
QuickGo view.
Family and domain databases
InterPro IPR001064; Crystallin.
Graphical view of domain structure.
Gene3D G3DSA:2.60.20.10; Crystallin; 2.
Pfam PF00030; Crystall; 2.
Pfam graphical view of domain structure.
PRINTS PR01367; BGCRYSTALLIN.
SMART SM00247; XTALbg; 2.
SMART graphical view of domain structure.
PROSITE PS50915; CRYSTALLIN_BETA_GAMMA; 4.
PROSITE graphical view of domain structure (profiles).
ProtoNet P07320.
Proteomic databases
PeptideAtlas P07320; -.
Genome annotation databases
Ensembl ENSG00000118231; Homo sapiens. [Contig view]
GeneID 1421; -.
KEGG hsa:1421; -.
Phylogenomic databases
HOGENOM P07320; -.
HOVERGEN P07320; -.
Other
LinkHub P07320; -.
NextBio 5811; -.
SOURCE CRYGD; Homo sapiens.
UniRef View cluster of proteins with at least 50% / 90% / 100% identity.
Keywords
3D-structure; Cataract; Direct protein sequencing; Disease mutation; Eye lens protein; Oxidation; Polymorphism; Repeat; Sensory transduction; Vision.
Features
SEVIEWER logo Feature table viewer FT aligner logo Feature aligner
KeyFrom   To Length Description FTId
INIT_MET   1     1        Removed. 
CHAIN   2   174  173     Gamma-crystallin D. PRO_0000057588
DOMAIN   2    40  39     Beta/gamma crystallin 'Greek key' 1. 
DOMAIN   41    83  43     Beta/gamma crystallin 'Greek key' 2. 
DOMAIN   88   128  41     Beta/gamma crystallin 'Greek key' 3. 
DOMAIN   129   171  43     Beta/gamma crystallin 'Greek key' 4. 
REGION   84    87  4     Connecting peptide. 
SITE   46    46  1     Susceptible to oxidation. 
VARIANT   15    15  1     R -> C (in progressive punctate cataract; forms disulfide-linked oligomers). VAR_010733 [3D]
VARIANT   24    24  1     P -> S (in PCC; dbSNP:rs28931605 [NCBI]). VAR_034955 [3D]
VARIANT   24    24  1     P -> T (in CCA3 and lamellar cataract; lowered solubility). VAR_021145 [3D]
VARIANT   37    37  1     R -> S (in cataract; very low solubility; crystallizes spontaneously). VAR_010734 [3D]
VARIANT   59    59  1     R -> H (in CACA; lowered solubility; crystallizes easily). VAR_010735 [3D]
VARIANT   102   102  1     M -> V. VAR_021146 [3D]
VARIANT   107   107  1     E -> A (in PCC). VAR_034956 [3D]
MUTAGEN   24    25        PN->TK: Wild-type solubility. 
MUTAGEN   24    24        P->S: Lowered solubility, but more soluble than T-23. 
MUTAGEN   24    24        P->TP: Wild-type solubility. 
MUTAGEN   24    24        P->V: Slightly lowered solubility. 
STRAND   3     9  7      
HELIX   10    12  3      
STRAND   13    21  9      
TURN   27    29  3      
STRAND   34    48  15      
TURN   49    51  3      
STRAND   52    58  7      
STRAND   60    65  6      
HELIX   66    69  4      
STRAND   72    74  3      
STRAND   78    82  5      
STRAND   89    95  7      
HELIX   96    98  3      
STRAND   99   107  9      
HELIX   112   114  3      
STRAND   123   129  7      
STRAND   131   136  6      
TURN   137   139  3      
STRAND   140   146  7      
STRAND   148   151  4      
HELIX   154   157  4      
STRAND   166   169  4      
Sequence information
Length: 174 AA [This is the length of the unprocessed precursor] Molecular weight: 20738 Da [This is the MW of the unprocessed precursor] CRC64: 437EC83FD79F12E4 [This is a checksum on the sequence]
        10         20         30         40         50         60 
MGKITLYEDR GFQGRHYECS SDHPNLQPYL SRCNSARVDS GCWMLYEQPN YSGLQYFLRR 

        70         80         90        100        110        120 
GDYADHQQWM GLSDSVRSCR LIPHSGSHRI RLYEREDYRG QMIEFTEDCS CLQDRFRFNE 

       130        140        150        160        170 
IHSLNVLEGS WVLYELSNYR GRQYLLMPGD YRRYQDWGAT NARVGSLRRV IDFS 

P07320 in FASTA format

View entry in original UniProtKB/Swiss-Prot format
View entry in raw text format (no links)
Report form for errors/updates in this UniProtKB/Swiss-Prot entry

BLAST logo BLAST submission on ExPASy/SIB
or at NCBI (USA)
Tools Sequence analysis tools: ProtParam, ProtScale, Compute pI/Mw, PeptideMass, PeptideCutter, Dotlet (Java)
PROSITE logo ScanProsite, MotifScan SWISS-MODEL Submit a homology modeling request to SWISS-MODEL
NPSA logo NPSA Sequence analysis tools

ExPASy logo ExPASy Home page Site Map Search ExPASy Contact us Swiss-Prot
 Hosted by ca flag CBR Canada Mirror sites: Australia  Brazil  China  Korea  Switzerland
Notice: This page will be replaced with www.uniprot.org. Please send us your feedback!